These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3081343)

  • 1. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
    Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
    Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
    Badenoch-Jones P; Ramshaw IA; Grant A
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiloride selectively inhibits the urokinase-type plasminogen activator.
    Vassalli JD; Belin D
    FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of epidermal plasminogen activator inhibitor.
    Hibino T; Izaki S; Izaki M
    FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
    Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
    J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
    Pereyra-Alfonso S; Haedo A; Bal de Kier Joffé E
    Int J Cancer; 1988 Jul; 42(1):59-63. PubMed ID: 3134309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP; Stephens RW
    Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA; Anderson JA; Bennett B
    Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of plasminogen activator of urokinase type with human serum].
    Vakulina OP; Popkova EV; Isachenkov VA
    Vopr Med Khim; 1988; 34(4):32-6. PubMed ID: 3143185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
    Hettle JA; Balekjian E; Tung PS; Fritz IB
    Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.